The outcome measures of pneumatic compression versus high-frequency vibration on quality of life in diabetic polyneuropathy patients

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202309863893315

Enrollment

Registered

2023-09-28

Start date

2023-07-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases Nutritional, Metabolic, Endocrine

Interventions

high frequency vibrator

pneumatic compression for both lower limbs for diabetic polyneuropathy

conventional program for both lower limbs with program for diabetic polyneuropathy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1-Sixty female patients. 2- Their ages will range from 50 to 60 years old. 3- Their HbA1c is more than 7% and less than 9 %. 4- Bilateral lower limb chronic DPN. 5- They suffer mild diabetic polyneuropathy for at least three months. 6- All the patients have significant decrease in the sensory (sural &superficial peroneal) lower limb nerve conduction velocity (from 20 m/s to 30 m/s). 7- All the patients have significant decrease in the motor (tibial &deep peroneal) lower limb nerve conduction velocity (from 20 m/s to 30 m/s). 8- All the patients have score more than in 20 Norfolk QOL-DN. 9- They all have score more than 8 on Toronto scoring system. 10- They have willingness to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Chest diseases (either obstructive or restrictive). 2. Smoker patient. 3. Clinical signs of a severe cardiac event. (eg, congestive heart failure), 4. Severe psychiatric or cognitive impairment, who unable to follow comment. 5. Neurological disorders affecting respiratory muscles or any muscular dystrophies (cervical disc or bulge). 6. Other type of polyneuropathy (Alcoholic, hereditary…..). a) Any patient that suffer from lower limb pathology that may interfere with the results like: b) Cellulitis. c) Lower limb pressure or diabetic ulcer. d) Atherosclerosis. e) Deep venous thrombosis.

Design outcomes

Primary

Measure	Time frame
sensory and motor nerve conduction velocity	—

Secondary

Measure	Time frame
The Norfolk Quality of Life Questionnaire-Diabetic Neuropathy (Norfolk QOL-DN):;Toronto clinical scoring system (TCSS);The Berg Balance Scale (BBS;brief painful inventory scale for diabetic peripheral neuropathy	—

Countries

Egypt

Contacts

Public Contacthend abdelmoneam

assistant professor cairo university

drhendpt@cu.edu.eg01115507195

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026